(2026). Anti‐amyloid therapy eligibility in a longitudinal brain‐donor cohort with post mortem confirmation. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Anti‐amyloid Therapy Eligibility in a Longitudinal Brain‐donor Cohort with Post Mortem Confirmation."
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Anti‐amyloid Therapy Eligibility in a Longitudinal Brain‐donor Cohort with Post Mortem Confirmation."
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.